• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性偏倚的免疫设定点预示寨卡病毒感染后中和抗体水平较低。

A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection.

机构信息

Departments of Otolaryngology-Head and Neck Surgery and Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.

Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA 94110, USA.

出版信息

Cell Rep. 2022 May 17;39(7):110815. doi: 10.1016/j.celrep.2022.110815.

DOI:10.1016/j.celrep.2022.110815
PMID:35584677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9151348/
Abstract

Although generating high neutralizing antibody levels is a key component of protective immunity after acute viral infection or vaccination, little is known about why some individuals generate high versus low neutralizing antibody titers. Here, we leverage the high-dimensional single-cell profiling capacity of mass cytometry to characterize the longitudinal cellular immune response to Zika virus (ZIKV) infection in viremic blood donors in Puerto Rico. During acute ZIKV infection, we identify widely coordinated responses across innate and adaptive immune cell lineages. High frequencies of multiple activated cell types during acute infection are associated with high titers of ZIKV neutralizing antibodies 6 months post-infection, while stable immune features suggesting a cytotoxic-skewed immune set point are associated with low titers. Our study offers insight into the coordination of immune responses and identifies candidate cellular biomarkers that may offer predictive value in vaccine efficacy trials aimed at inducing high levels of antiviral neutralizing antibodies.

摘要

尽管产生高中和抗体水平是急性病毒感染或接种疫苗后保护性免疫的关键组成部分,但对于为什么有些人产生高中和抗体滴度而有些人产生低中和抗体滴度知之甚少。在这里,我们利用液滴式多重流式细胞术的高维单细胞分析能力,来描述波多黎各病毒血症献血者感染寨卡病毒(ZIKV)后的纵向细胞免疫反应。在急性 ZIKV 感染期间,我们发现先天免疫和适应性免疫细胞谱系之间存在广泛的协调反应。在急性感染期间,多种激活的细胞类型高频出现与感染后 6 个月的 ZIKV 中和抗体高滴度相关,而稳定的免疫特征表明细胞毒性偏向的免疫设定点与低滴度相关。我们的研究提供了对免疫反应协调的深入了解,并确定了候选细胞生物标志物,这些标志物可能在旨在诱导高水平抗病毒中和抗体的疫苗功效试验中提供预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/0183a49e9c0e/nihms-1808942-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/a16d59eca807/nihms-1808942-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/68e88115f325/nihms-1808942-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/954b344bce8a/nihms-1808942-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/67430014d7c3/nihms-1808942-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/0183a49e9c0e/nihms-1808942-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/a16d59eca807/nihms-1808942-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/68e88115f325/nihms-1808942-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/954b344bce8a/nihms-1808942-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/67430014d7c3/nihms-1808942-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/9151348/0183a49e9c0e/nihms-1808942-f0006.jpg

相似文献

1
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection.细胞毒性偏倚的免疫设定点预示寨卡病毒感染后中和抗体水平较低。
Cell Rep. 2022 May 17;39(7):110815. doi: 10.1016/j.celrep.2022.110815.
2
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.重组黑猩猩腺病毒疫苗AdC7-M/E可预防寨卡病毒感染及睾丸损伤。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01722-17. Print 2018 Mar 15.
3
Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.带有包膜蛋白共价二聚体的寨卡病毒样颗粒可保护小鼠免受致死性挑战。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01415-20.
4
Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.亚洲和美洲寨卡病毒和登革热病毒感染后的抗体交叉中和的纵向分析。
J Infect Dis. 2018 Jul 13;218(4):536-545. doi: 10.1093/infdis/jiy164.
5
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.在一位有登革热感染史的供者中,接种 Zika 疫苗诱导产生了强效的 Zika 和登革热交叉中和抗体。
Nat Med. 2020 Feb;26(2):228-235. doi: 10.1038/s41591-019-0746-2. Epub 2020 Feb 3.
6
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.寨卡病毒免疫血清的广泛中和活性鉴定出单一病毒血清型。
Cell Rep. 2016 Aug 9;16(6):1485-1491. doi: 10.1016/j.celrep.2016.07.049. Epub 2016 Jul 29.
7
Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.寨卡病毒样颗粒疫苗及报告基因检测法的研发
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.00834-17. Print 2017 Oct 15.
8
Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice.细胞和体液免疫可保护小鼠免受阴道寨卡病毒感染。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.00038-18. Print 2018 Apr 1.
9
Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.先前的登革热病毒3型感染可调节恒河猴随后对寨卡病毒感染的浆母细胞反应。
mBio. 2024 Mar 13;15(3):e0316023. doi: 10.1128/mbio.03160-23. Epub 2024 Feb 13.
10
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.儿童感染登革热和 Zika 病毒会产生长期持续存在的交叉反应性保护性和增强性抗体。
Sci Transl Med. 2021 Oct 6;13(614):eabg9478. doi: 10.1126/scitranslmed.abg9478.

引用本文的文献

1
Combination immunotherapy induces post-intervention control of HIV.联合免疫疗法可诱导HIV的干预后控制。
Res Sq. 2025 Mar 19:rs.3.rs-6141479. doi: 10.21203/rs.3.rs-6141479/v1.
2
Zika virus: an overview update.寨卡病毒:最新综述
Curr Opin HIV AIDS. 2025 May 1;20(3):294-302. doi: 10.1097/COH.0000000000000926. Epub 2025 Mar 17.
3
Comprehensive analysis of early T cell responses to acute Zika Virus infection during the first epidemic in Bahia, Brazil.巴西巴伊亚州首次寨卡病毒流行期间急性寨卡病毒感染早期 T 细胞应答的综合分析。

本文引用的文献

1
Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection.自然感染登革病毒后与疾病严重程度和长期中和抗体滴度相关的免疫细胞表型。
Cell Rep Med. 2021 May 18;2(5):100278. doi: 10.1016/j.xcrm.2021.100278.
2
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
3
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
PLoS One. 2024 May 9;19(5):e0302684. doi: 10.1371/journal.pone.0302684. eCollection 2024.
时间分辨系统免疫学揭示了与致命 COVID-19 相关的晚期节点。
Cell. 2021 Apr 1;184(7):1836-1857.e22. doi: 10.1016/j.cell.2021.02.018. Epub 2021 Feb 10.
4
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.B 细胞与 HIV-1 始祖病毒包膜的结合可预测广泛中和抗体的产生。
Cell Host Microbe. 2021 Apr 14;29(4):564-578.e9. doi: 10.1016/j.chom.2021.01.016. Epub 2021 Mar 3.
5
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.非典型 B 细胞是 B 细胞的另一种谱系的一部分,参与人类对疫苗接种和感染的反应。
Cell Rep. 2021 Feb 9;34(6):108684. doi: 10.1016/j.celrep.2020.108684.
6
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.综合免疫动力学定义了 COVID-19 严重程度和抗体反应的相关因素。
Cell Rep Med. 2021 Mar 16;2(3):100208. doi: 10.1016/j.xcrm.2021.100208. Epub 2021 Feb 5.
7
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.用于长期应用的寨卡报告病毒粒子的抗原性、稳定性和重现性。
PLoS Negl Trop Dis. 2020 Nov 18;14(11):e0008730. doi: 10.1371/journal.pntd.0008730. eCollection 2020 Nov.
8
Landscape of coordinated immune responses to H1N1 challenge in humans.人类对 H1N1 挑战的协调免疫反应景观。
J Clin Invest. 2020 Nov 2;130(11):5800-5816. doi: 10.1172/JCI137265.
9
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
10
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.人类对轻度与重度 COVID-19 感染免疫的系统生物学评估。
Science. 2020 Sep 4;369(6508):1210-1220. doi: 10.1126/science.abc6261. Epub 2020 Aug 11.